Experts point to a combination of environmental factors and lifestyle factors, such as diets high in red meat and ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 7, 2026 (HealthDay News) — Ozempic and Wegovy might help people avoid ...

Newcastle University researchers discover exercise rapidly alters blood chemistry to support DNA repair in colon cancer cells ...

A recent study revealed that GLP-1 drugs, Ozempic and Wegovy, primarily used for diabetes and weight loss, may assist in ...

Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...

Weight loss and diabetes drugs such as Ozempic and Wegovy may help reduce colon cancer risk, a new study presented at the ...

Many Americans aren't getting enough fiber, while colorectal cancer rates are increasing in younger adults. Is fibermaxxing ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Colon cancer will be diagnosed in approximately 150,000 Americans in 2024. It’s the fourth most diagnosed cancer in the United States and one of the leading causes of cancer deaths, according to the U ...

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

Dr. Sandy Kavalukas, an oncologist with University of Louisville Health, said that a new change allows patients with a family ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in colon cancer risk. Aging, more ...